Hostname: page-component-6766d58669-7cz98 Total loading time: 0 Render date: 2026-05-19T00:24:45.575Z Has data issue: false hasContentIssue false
  • English
  • Français

Mast cells positive for cluster of differentiation 117 protein: are they players or conductor in the orchestra of cholesteatoma?

Published online by Cambridge University Press:  15 June 2012

A O Calli ,
A Sari ,
F Cakalagaoglu ,
A A Altinboga ,
C Calli  and
S Oncel
A O Calli*
Affiliation:
Department of Pathology, Izmir Training and Research Hospital, Turkey
A Sari
Affiliation:
Department of Pathology, Izmir Training and Research Hospital, Turkey
F Cakalagaoglu
Affiliation:
Department of Pathology, Izmir Training and Research Hospital, Turkey
A A Altinboga
Affiliation:
Department of Pathology, Izmir Training and Research Hospital, Turkey
C Calli
Affiliation:
Department of Head and Neck Surgery, Izmir Training and Research Hospital, Turkey
S Oncel
Affiliation:
Department of Head and Neck Surgery, Izmir Training and Research Hospital, Turkey
*
Address for correspondence: Dr Aylin Orgen Calli, Izmir Training and Research Hospital, Department of Pathology, Yesilyurt, Izmir 35290, Turkey Fax: +90 232 2434343 E-mail: calliaylin@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The pathogenesis of cholesteatoma remains unclear, despite several theories. Alterations in the density of mast cells positive for cluster of differentiation 117 protein (also known as CD117) can be critical to cholesteatoma formation, due to the effect on keratinocyte growth factor production. This study aimed to investigate the potential role of these mast cells in cholesteatoma pathogenesis.

Methods:

The number and density of mast cells positive for cluster of differentiation 117 protein were immunohistochemically analysed in 52 patients: 22 with chronic otitis media alone (group one), 25 with chronic otitis media with cholesteatoma (group two) and five controls.

Results:

The number of these mast cells was much higher in group two (in cholesteatoma matrix tissue) than in group one (in chronic otitis media granulation tissue) or the controls (in normal post-auricular skin). The density of these mast cells was significantly greater in group two than in group one or the controls (p < 0.05). The number and density of these mast cells was much greater in group one than in controls (p < 0.01).

Conclusion:

Mast cells positive for cluster of differentiation 117 protein could play a role in cholesteatoma formation. Further investigation of the role of these mast cells in cholesteatoma may suggest new ways of addressing this disorder, and may enable the development of targeted treatments.

Keywords

Mast CellCD117CholesteatomaImmunohistochemistryPathogenesis

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 126 , Issue 8 , August 2012 , pp. 775 - 779
Copyright
Copyright © JLO (1984) Limited 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1 Michaels, L. Ear, Nose and Throat Histopathology. London: Springer-Verlag, 1987 CrossRefGoogle Scholar
2 Huisman, MA, de Heer, E, Ten Dijke, P, Grote, JJ. Transforming growth factor beta and wound healing in human cholesteatoma. Laryngoscope 2008;118:94–8CrossRefGoogle ScholarPubMed
3 Albino, AP, Reed, JA, Bogdany, JK, Sassoon, J, Parisier, SC. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment. Am J Otol 1998;19:266–72Google ScholarPubMed
4 Olszewska, E, Wagner, M, Bernal-Sprekelsen, M, Ebmeyer, J, Dazert, S, Hildmann, H et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 2004;261:6–24 CrossRefGoogle ScholarPubMed
5 Albino, AP, Parisier, SC. The enigmatic biology of human cholesteatoma. In: Ars, B, ed. Pathogenesis in Cholesteatoma. The Hague: Kugler, 1999;37–65 Google Scholar
6 Albino, AP, Kimmelman, CP, Parisier, SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998;19:7–19 Google ScholarPubMed
7 Noli, C, Miolo, A. The mast cell in wound healing. Vet Dermatol 2001;12:303–13CrossRefGoogle ScholarPubMed
8 Artuc, M, Steckelings, UM, Henz, BM. Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J Invest Dermatol 2002;118:391–5CrossRefGoogle ScholarPubMed
9 Vennix, PP, Kuijpers, W, Tonnaer, EL, Peters, TA, Ramaekers, FC. Cytokeratins in induced epidermoid formations and cholesteatoma lesions. Arch Otolaryngol Head Neck Surg 1990;116:560–5CrossRefGoogle ScholarPubMed
10 Broekaert, D, Coucke, P, Leperque, S, Ramaekers, F, Van Muijen, G, Boedts, D et al. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol 1992;101:931–8CrossRefGoogle ScholarPubMed
11 Ergün, S, Zheng, X, Carlsöö, B. Antigen expression of epithelial markers, collagen IV and Ki6 7 in middle ear cholesteatoma. An immunohistochemical study. Acta Otolaryngol 1994;114:295–302 CrossRefGoogle Scholar
12 Cairns, JA, Walls, AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 1996;156:275–83CrossRefGoogle ScholarPubMed
13 Walsh, LJ, Trinchieri, G, Waldorf, HA, Whitaker, D, Murphy, GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 1991;88:4220–4CrossRefGoogle ScholarPubMed
14 Brown, JK, Jones, CA, Tyler, CL, Ruoss, SJ, Hartmann, T, Caughey, GH. Tryptase-induced mitogenesis in airway smooth muscle cells. Potency, mechanisms, and interactions with other mast cell mediators. Chest 1995;107(suppl):95–96S CrossRefGoogle ScholarPubMed
15 Valent, P. The riddle of the mast cell: kit (CD117)-ligand as the missing link? Immunol Today 1994;15:111–14CrossRefGoogle ScholarPubMed
16 Edling, CE, Hallberg, B. c-Kit – a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol 2007;39:1995–8CrossRefGoogle ScholarPubMed
17 Jensen, BM, Metcalfe, DD, Gilfillan, AM. Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation. Inflamm Allergy Drug Targets 2007;6:57–62 CrossRefGoogle ScholarPubMed
18 Metcalfe, DD, Baram, D, Mekori, YA. Mast cells. Physiol Rev 1997;77:1033–79CrossRefGoogle ScholarPubMed
19 Sharma, B, Sriram, G, Saraswathi, TR, Sivapathasundharam, B. Immunohistochemical evaluation of mast cells and angiogenesis in oral squamous cell carcinoma. Indian J Dent Res 2010;21:260–5Google ScholarPubMed
20 Louw, L. Acquired cholesteatoma pathogenesis: stepwise explanations. J Laryngol Otol 2010;124:587–93CrossRefGoogle ScholarPubMed
21 Friedland, DR, Eernisse, R, Erbe, C, Gupta, N, Cioffi, JA. Cholesteatoma growth and proliferation: post-transcriptional regulation by microRNA-21. Otol Neurotol 2009;30:998–1005 CrossRefGoogle ScholarPubMed
22 Li, W, Dasgeb, B, Phillips, T, Li, Y, Chen, M, Garner, W et al. Wound-healing perspectives. Dermatol Clin 2005;23:181–92CrossRefGoogle ScholarPubMed
23 Artuc, M, Hermes, B, Steckelings, UM, Grützkau, A, Henz, BM. Mast cells and their mediators in cutaneous wound healing – active participants or innocent bystanders? Exp Dermatol 1999;8:1–16 CrossRefGoogle ScholarPubMed
24 Dowdall, JF, Winter, DC, Baird, AW, Bouchier-Hayes, D. Biological role and clinical implications of mast cells in surgery. Surgery 2002;132:1–4 CrossRefGoogle ScholarPubMed
25 Bujía, J, Kim, C, Holly, A, Sudhoff, H, Ostos, P, Kastenbauer, E. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol 1996;17:203–6Google ScholarPubMed
26 Shinoda, H, Huang, CC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope 1995;105:1232–7CrossRefGoogle ScholarPubMed
27 Welker, P, Grabbe, J, Czarnetzki, BM. Human keratinocytes release mast cell differentiation factors other than stem cell factor. Int Arch Allergy Immunol 1995;107:139–41CrossRefGoogle ScholarPubMed
28 Saarinen, J, Kalkkinen, N, Welgus, HG, Kovanen, PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 1994;269:18134–40CrossRefGoogle ScholarPubMed
29 Dabbous, MK, North, SM, Haney, L, Tipton, DA, Nicolson, GL. Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin Exp Metastasis 1995;13:33–41 CrossRefGoogle ScholarPubMed
30 Zoog, SJ, Itano, A, Trueblood, E, Pacheco, E, Zhou, L, Zhang, X et al. Antagonists of CD117 (cKit) signaling inhibit mast cell accumulation in healing skin wounds. Cytometry A 2009;75:189–98CrossRefGoogle ScholarPubMed